A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Institute for Clinical and Experimental Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Thomas Jefferson University
City of Hope Medical Center
Thomas Jefferson University
National Cancer Institute (NCI)
University of California, San Diego
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Sumitomo Pharma Switzerland GmbH
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Medical College of Wisconsin
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
City of Hope Medical Center
Stanford University
University of Nebraska
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Rockefeller University
Milton S. Hershey Medical Center
Case Comprehensive Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Medical College of Wisconsin
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)